Relation Between Activated Clotting Time During Angioplasty and Abrupt Closure
- 15 February 1996
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 93 (4) , 667-671
- https://doi.org/10.1161/01.cir.93.4.667
Abstract
Background The purpose of this study was to determine whether the degree of heparin anticoagulation during coronary angioplasty, as measured by the activated clotting time, is related to the risk of abrupt vessel closure. Methods and Results Sixty-two cases of in- and out-of-laboratory abrupt closure in patients in whom intraprocedure activated clotting times were measured were identified from a population of 1290 consecutive patients who underwent nonemergency coronary angioplasty. This group was compared with a matched control population of 124 patients who did not experience abrupt closure. Relative to the control population, patients who experienced abrupt closure had significantly lower initial (median, 350 seconds [25th to 75th percentile, 309 to 401 seconds] versus 380 seconds [335 to 423 seconds], P =.004) and minimum (345 seconds [287 to 387 seconds] versus 370 seconds [321 to 417 seconds], P =.014) activated clotting times. Higher activated clotting times were not associated with an increased likelihood of major bleeding complications. Within this population, a strong inverse linear relation existed between the activated clotting time and the probability of abrupt closure. Conclusions This study demonstrates a significant inverse relation between the degree of anticoagulation during angioplasty and the risk of abrupt closure. A minimum target activated clotting time could not be identified; rather, the higher the intensity of anticoagulation, the lower the risk of abrupt closure.Keywords
This publication has 20 references indexed in Scilit:
- Predicting the risk of abrupt vessel closure after angioplasty in an individual patientJournal of the American College of Cardiology, 1994
- Incidence, predictors, and management of acute coronary occlusion after coronary angioplastyAmerican Heart Journal, 1994
- Comparison of Hemochron and HemoTec activated coagulation time target values during percutaneous transluminal coronary angioplastyJournal of the American College of Cardiology, 1994
- Recent changes in the management and outcome of acute closure after percutaneous transluminal coronary angioplastyThe American Journal of Cardiology, 1993
- Abrupt vessel closure complicating coronary angioplasty: Clinical, angiographic and therapeutic profileJournal of the American College of Cardiology, 1992
- Monitoring the effect of heparin by measurement of activated clotting time during and after percutaneous transluminal coronary angioplasty.Heart, 1990
- Adequate heparinization during PTCA: Assessment using activated clotting timesCatheterization and Cardiovascular Diagnosis, 1989
- Coronary angioplasty for unstable angina: Immediate and late results in 200 consecutive patients with identification of risk factors for unfavorable early and late outcomeJournal of the American College of Cardiology, 1988
- Aspirin and Dipyridamole in the Prevention of Re-Stenosis after Percutaneous Transluminal Coronary AngioplastyNew England Journal of Medicine, 1988
- Emergency Coronary Angioplasty in Refractory Unstable AnginaNew England Journal of Medicine, 1985